Clincosm LogoSign in Get a demo

pancreatic adenocarcinoma

Showing 26 - 50 of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses

Completed
  • Pancreatic Adenocarcinoma
  • +2 more
  • endoscopic ultrasound-guided fine needle biopsy
  • Bologna, Italy
    Gastrointestinal Unit, University of Bologna/Hospital of Imola
Nov 7, 2022

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Houston (Aerobic Exercise, Dietary Intervention, Nutritional

Withdrawn
  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Aerobic Exercise
  • +5 more
  • (no location specified)
Oct 26, 2022

Pancreatic Adenocarcinoma Trial in Stanford (ExAblate 2100)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • ExAblate 2100
  • Stanford, California
    Stanford Cancer Center
Oct 25, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Carcinoma
  • Birmingham, Alabama
  • +806 more
Oct 18, 2022

Pancreatic Adenocarcinoma Trial in France, United Kingdom, United States (eryaspase, Gemcitabine plus Abraxane, Irinotecan plus

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • Scottsdale, Arizona
  • +15 more
Sep 27, 2022

Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

Terminated
Has Results
  • Pancreatic Adenocarcinoma
  • +2 more
  • Pembrolizumab
  • Wild-type Reovirus
  • Chicago, Illinois
    Northwestern University
Sep 6, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma, Cholangiocarcinoma Trial in Cleveland, Philadelphia (Pancreatectomy,

Recruiting
  • Acinar Cell Carcinoma
  • +7 more
  • Pancreatectomy
  • Lavage
  • Cleveland, Ohio
  • +1 more
Sep 7, 2022

Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Blood Specimen
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 5, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

Completed
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +6 more
  • Houston, Texas
  • +4 more
Aug 31, 2022

Predicting Effective Therapy in Pancreatic Cancer

Active, not recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • CTC isolocation and analysis
  • Basking Ridge, New Jersey
  • +3 more
Aug 30, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland

Recruiting
  • Hereditary Pancreatic Carcinoma
  • +2 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Ferumoxytol
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 16, 2022

Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in Houston (Autologous DC vaccine)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer
  • Autologous DC vaccine
  • Houston, Texas
  • +2 more
Aug 17, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022

Pancreatic Adenocarcinoma Trial in United States (Durvalumab, Stereotactic Ablative Body Radiotherapy (SABR))

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Durvalumab
  • Stereotactic Ablative Body Radiotherapy (SABR)
  • Los Angeles, California
  • +7 more
Aug 11, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • Hamilton, Ontario, Canada
    Juravinski Hospital
Aug 5, 2022

Pancreatic Adenocarcinoma, Pancreatic Cancer Resectable Trial in Cádiz (Folfirinox and Stereotactic Body Radiotherapy)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer Resectable
  • Folfirinox and Stereotactic Body Radiotherapy
  • Cádiz, Spain
    Hospital Puerta del Mar
Aug 5, 2022